The effect of exercise and antioxidant enzyme levels in syndrome X and coronary slow flow phenomenon: An observational study;Sendrom X ve yavaş koroner aki{dotless}m fenomeninde antioksidan enzim düzeyleri ve egzersizin etkisi: Gözlemsel bir çali{dotless}şma

Anadolu Kardiyoloji Dergisi

Volumn 13, Issue 7, 2013, Pages 641-646

  Kaplan, Özgür ^a   Meriç, Murat ^a   Acar, Zeydin ^a   Kale, Abdurrahman ^a   Demircan, Sabri ^a   Yilmaz, Özcan ^a   Demircan, Günnur ^a   Yilmaz Miroǧlu, Yeliz ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Antioxidant enzymes; Coronary slow flow; Syndrome X

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; ANTIOXIDANTS;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME ASSAY; ENZYME BLOOD LEVEL; ERYTHROCYTE; EXERCISE; FEMALE; FLOW RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; SYNDROME X; BLOOD; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; EXERCISE THERAPY; HUMANS; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

ANTIOXIDANTS; CASE-CONTROL STUDIES; CATALASE; CORONARY ARTERY DISEASE; EXERCISE THERAPY; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME;

EID: 84887807708     PISSN: None     EISSN: 13080032     Source Type: Journal    
DOI: 10.5152/akd.2013.186     Document Type: Article

References (27)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-26. [CrossRef]
2. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries-a new angiographic finding. Am Heart J 1972; 84: 66-71. [CrossRef]
3. Sezgin AT, Si{dotless}ǧi{dotless}rci{dotless} M, Barutçu I, Topal E, Sezgin N, Özdemir R, et al. Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 2003; 14: 155-61. [CrossRef]
4. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986; 74: 964-72. [CrossRef]
5. Mangieri M, Macchiarelli G, Ciavolella M, Barilla F, Avella A, Martinotti A, et al. Slow coronary flow: clinical and histopatological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 1996; 37: 375-81. [CrossRef]
6. Kurtoǧlu N, Akçay A, Dindar I. Usefulness of oral dipiridamole therapy for angiographic slow coronary artery flow. Am J Cardiol 2001; 87(Suppl 8A): 777-9. [CrossRef]
7. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Eng J Med 2002; 346: 1948-53. [CrossRef]
8. Chen LC, Chen JW, Wu MH, Liu JC, Lan GY, Ding PY, et al. Differential coronary calcification on electron-beam CT between syndrome X and coronary artery disease in patients and chronic stable angina pectoris. Chest 2001; 120: 1525-33. [CrossRef]
9. Potts SG, Bass CM. Psychological morbidity in patients with chest pain and normal or near normal coronary arteries: a long-term follow up study. Psychol Med 1995; 25: 339-47. [CrossRef]
10. Tang NP, Wang LS, Yang L, Gu HJ, Sun QM, Cong RH, et al. Genetic variant in glutathione peroxidase 1 gene is associated with an increased risk of coronary artery disease in a Chinese population. Clin Chim Acta 2008; 395: 89-93. [CrossRef]
11. Misra P, Reddy PC, Shukla D, Caldito GC, Yerra L, Aw TY. In-stent stenosis: potential role of increased oxidative stress and glutathione-linked detoxification mechanisms. Angiology 2008; 59; 469-74. [CrossRef]
12. Kaminski K, Bonda T, Wojtkowska I, Dobrzycki S, Kralisz P, Nowak K, et al. Oxidative stress and antioxidative defense parameters early after reperfusion therapy for acute myocardial infarction. Acute Card Care 2008; 10: 121-6. [CrossRef]
13. Demircan S, Yazi{dotless}ci{dotless} M, Di{dotless}raman E, Demircan G, Ki{dotless}li{dotless}çaslan F, Durna K, et al. The effect of glucose-insulin-potassium treatment on myocardial oxidative stress in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Coron Artery Dis 2008, 19: 99-104. [CrossRef]
14. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-88. [CrossRef]
15. Tanri{dotless}verdi H, Evrengül H, Enli Y, Kuru O, Seleci D, Tanri{dotless}verdi S, et al. Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow. Cardiology 2007; 107: 313-20. [CrossRef]
16. Gür M, Yi{dotless}ldi{dotless}z A, Demirbaǧ R, Yi{dotless}lmaz R, Aslan M, Özdoǧru I, et al. Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers. Coron Artery Dis 2007; 18: 89-95. [CrossRef]
17. Çamsari{dotless} A, Pekdemir H, Çicek D, Polat G, Akkuş MN, Döven O, et al. Endothelin-1 and nitric oxide concentrations and their response to exercise in patients with slow coronary flow. Circ J 2003; 67: 1022-8. [CrossRef]
18. Ri{dotless}za Erbay A, Turhan H, Yaşar AS, Ayaz S, Şahin O, Senen K, et al. Elevated level of plasma homocysteine in patients with slow coronary flow. Int J Cardiol 2005; 102: 419-23. [CrossRef]
19. Fragasso G, Chierchia SL, Arioli F, Carandente O, Gerosa S, Carlino M, et al, Coronary slow-flow causing transient myocardial hypoperfusion in patients with cardiac syndrome X: long-term clinical and functional prognosis. Int J Cardiol 2009; 137: 137-44. [CrossRef]
20. Duthie GG, Robertson JD, Maughan RJ, Morrice PC. Blood antioxidant status and erythrocyte lipid peroxidation following distance running. Arch Biochem Biophys 1990; 282: 78-83. [CrossRef]
21. Fadi{dotless}lli{dotless}oǧlu E, Kaya B, Uz E, Emre MH, Ünal S. Effects of moderate exercise on mild depressive mood, antioxidants and lipid peroxidation. Bull Clin Psychopharmacol 2000; 10: 194-200.
22. Pizzi C, Manfrini O, Fontana F, Bugiardini R. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac syndrome X: role of superoxide dismutase activity. Circulation 2004; 109; 53-8. [CrossRef]
23. Akyüz F, İnal M, Turgut A. Yüzücülerde aerobik ve anaerobik metabolizmani{dotless}n serbest radikaller üzerine etkisi. Klinik Gelişim 1998; 11: 409-11.
24. Espinola-Klein C, Rupprecht HJ, Bickel C, Schnabel R, Genth-Zotz S, Torzewski M, et al. Glutathione peroxidase-1 activity, atherosclerotic burden and cardiovascular prognosis. Am J Cardiol 2007; 99: 808-12. [CrossRef]
25. Torzewski M, Ochsenhirt V, Kleschyov AL, Oelze M, Daiber A, Li H, et al. Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2007; 27; 850-7. [CrossRef]
26. Erdamar H, Şen N, Tavil Y, Yazi{dotless}ci{dotless} HU, Turfan M, Poyraz F, et al. The effect of nebivolol treatment on oxidative stress and antioxidant status in patients with cardiac syndrome-X. Coron Artery Dis 2009; 20: 238-4. [CrossRef]
27. Amirkhizi F, Siassi F, Djalali M, Foroushani AR. Assessment of antioxidant enzyme activities in erythrocytes of prehypertensive and hypertensive women. J Res Med Sci 2010; 15: 270-8.